USE OF EPINEPHRINE NASAL SPRAY. (NEW)

Printer-friendly: Click to view
View NCGA Bill Details(link is external)2025-2026 Session
House Bill 397 (Public) Filed Thursday, March 13, 2025
AN ACT TO ALLOW THE USE OF EPINEPHRINE NASAL SPRAY IN ADDITION TO AUTO-INJECTORS.
Intro. by Lambeth.

Status: Placed On Cal For 04/09/2025 (House action) (Apr 3 2025)

SOG comments (1):

Long title change

House committee substitute to the first edition changes the long title. Previous title was AN ACT TO ALLOW THE USE OF EPINEPHRINE NASAL SPRAY IN ADDITION TO AUTO-INJECTORS IN SCHOOLS.

H 397

Bill Summaries:

  • Summary date: Apr 1 2025 - View Summary

    House committee substitute to the 1st edition makes the following changes. Modifies the emergency action plan required under GS 115C-375.2A by requiring the school to contact the student’s guardian if applicable (currently requires school to only contact the student’s parent or physician). Makes an additional conforming change to refer to the use of "epinephrine delivery systems" instead of "epinephrine auto injectors" in GS 116-239.8 (UNC laboratory schools).

    Modifies the immunity for emergency treatment using epinephrine under GS 90-21.15A so that it encompasses epinephrine delivery systems (currently, limited to epinephrine auto injectors), which it defines as a disposable drug delivery system that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering a potentially fatal reaction to anaphylaxis, including nasal sprays and injectors with a spring-activated, concealed needle. Makes conforming changes throughout the statute. Makes conforming changes to act’s long and short titles.


  • Summary date: Mar 13 2025 - View Summary

    Amends GS 115C-375.2 by amending the provision governing the policies adopted by local boards of education regulating when a student with asthma or subject to anaphylactic reactions can possess and self-administer asthma medication to define asthma medication to include epinephrine delivery systems, no longer limiting it to epinephrine auto injectors. Makes conforming changes to refer to the use of "epinephrine delivery systems" instead of "epinephrine auto injectors" in GS 115C-375.2A (concerning school supply of epinephrine delivery systems), GS 115C-218.75 (concerning health and safety standards for charter schools), and GS 115C-238.66 (concerning the supply of epinephrine delivery systems in regional schools). Also amends GS 115C-375.2A to provide that "epinephrine delivery system" includes nasal sprays and injectors with a spring-activated concealed needle. Applies beginning with the 2025-26 school year.